Us Bancorp \De\ Praxis Precision Medicines, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.75 - $11.34 $110 - $714	-63 Reduced 23.51%	205 $1,000
Q1 2022 May 11, 2022	SELL	$10.21 - $20.29 $4,911 - $9,759	-481 Reduced 64.22%	268 $3,000
Q4 2021 Feb 11, 2022	BUY	$16.76 - $22.99 $8,698 - $11,931	519 Added 225.65%	749 $15,000
Q3 2021 Nov 10, 2021	BUY	$13.15 - $22.56 $657 - $1,128	50 Added 27.78%	230 $4,000
Q2 2021 Aug 05, 2021	BUY	$18.28 - $33.05 $3,290 - $5,948	180 New	180 $3,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.